CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells.

Thymidylate synthase (TS) is a dNTP synthetic enzyme and is also a target enzyme of 5-fluorouracil (5-FU). 5-FU is one of the anticancer agents most frequently used for the treatment of colorectal cancers. However, the clinical rate of response to its use as a single agent is not exceptionally high. Therefore, various combination chemotherapies have been devised. The elevated expression of TS in cancer cells is a serious obstacle in the clinical use of 5-FU. In the present study, TS expression was up-regulated by the knockout of the p21WAF1/CIP1 gene in human colorectal cancer HCT116 cells, suggesting that TS expression is mediated through the inhibition of cyclin-dependent kinase (CDK). Based on these findings, we tested whether the CDK inhibitor (CDKI) SU9516, acted as a suppressor of TS. SU9516 effectively reduced the expression of TS in a dose-dependent manner. Furthermore, the reduction of TS expression resulted in enhancement of the sensitivity to 5-FU in human colon cancer DLD-1 cells. Thus, SU9516 might be a promising compound for combination chemotherapy with 5-FU.

[1]  T. Jacks,et al.  Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents , 2004, Oncogene.

[2]  F. Kaye,et al.  Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme. , 2004, Cancer cell.

[3]  J. C. Schmitz,et al.  Small Interfering Double-Stranded RNAs as Therapeutic Molecules to Restore Chemosensitivity to Thymidylate Synthase Inhibitor Compounds , 2004, Cancer Research.

[4]  Terence Hui,et al.  SU9516: biochemical analysis of cdk inhibition and crystal structure in complex with cdk2. , 2003, Biochemical and biophysical research communications.

[5]  M. Fukushima,et al.  Quantitative Measurement of Thymidylate Synthase and Dihydropyrimidine Dehydrogenase mRNA Level in Gastric Cancer by Real‐time RT‐PCR , 2002, Japanese journal of cancer research : Gann.

[6]  Steven P. Angus,et al.  Retinoblastoma Tumor Suppressor Targets dNTP Metabolism to Regulate DNA Replication* , 2002, The Journal of Biological Chemistry.

[7]  M. Fukushima,et al.  Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells. , 2002, International journal of oncology.

[8]  G. Peters,et al.  Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. , 2002, Biochimica et biophysica acta.

[9]  S. Monfardini,et al.  Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer. , 2002, Cancer treatment reviews.

[10]  G. Watanabe,et al.  Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  G. Mcmahon,et al.  A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells. , 2001, Cancer research.

[12]  P. Hoff.  The Tegafur-Based Dihydropyrimidine Dehydrogenase Inhibitory Fluoropyrimidines, UFT/Leucovorin (ORZEL and S-1: a Review of Their Clinical Development and Therapeutic Potential , 2000, Investigational New Drugs.

[13]  G. Aherne,et al.  Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  C. Cordon-Cardo,et al.  Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. , 2000, Cancer research.

[15]  N. Dyson.  The regulation of E2F by pRB-family proteins. , 1998, Genes & development.

[16]  M. Fukushima,et al.  Preparation of the antibodies against recombinant human thymidylate synthase for the detection of its intratumoral levels and the application to sensitivity-study of 5-fluorouracil. , 1997, Oncology reports.

[17]  K. Kinzler,et al.  p21 is necessary for the p53-mediated G1 arrest in human cancer cells. , 1995, Cancer research.

[18]  J. Nevins,et al.  Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes , 1995, Molecular and cellular biology.

[19]  H. Pinedo,et al.  Fluorouracil: biochemistry and pharmacology. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  L. Johnson,et al.  Stable inhibition of human thymidylate synthase expression following retroviral introduction of an siRNA gene , 2006, Cancer Gene Therapy.

[21]  S. Asai,et al.  Thymidylate Synthase Expression Correlates Closely with E 2 F 1 Expression in Colon Cancer 1 , 2000 .